HUTCHMED (China) Limited (HCM)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

225.00p
   
  • Change Today:
      0.50p
  • 52 Week High: 325.00p
  • 52 Week Low: 189.00p
  • Currency: UK Pounds
  • Shares Issued: 872.11m
  • Volume: 41,560
  • Market Cap: £1,962.25m
  • RiskGrade: 226
  • Beta: 0.06

Latest ShareCast News

Hutchmed to get milestone payment after China drug approval

By Josh White

Date: Monday 30 Jun 2025

(Sharecast News) - Hutchmed announced on Monday that China's National Medical Products Administration (NMPA) has approved the new drug application for the combination of 'Orpathys'. Or savolitinib, and 'Tagrisso', or osimertinib, to treat patients with locally advanced or metastatic EGFR mutation-positive non-squamous non-small cell lung cancer (NSCLC) with MET amplification following progression on EGFR TKI therapy.

HCM ShareCast News

Hutchmed new drug application accepted in China 05-Jun-2025 ShareCast
Hutchmed China upbeat on results from lung cance... 02-Jun-2025 ShareCast
Hutchmed enrols patients for phase two savolitin... 22-Apr-2025 ShareCast
Hutchmed renal cell carcinoma trial meets primar... 19-Mar-2025 ShareCast
Hutchmed announces progress, hits milestone with... 02-Jan-2025 ShareCast

HCM Regulatory News

2025 Interim Results 07-Aug-2025 12:00 RNS
HUTCHMED to Announce 2025 Half-Year Results 03-Jul-2025 09:30 RNS
Update on Joint Corporate Brokers in London 02-Jul-2025 10:00 RNS
China Approval based on Phase III SACHI Trial 30-Jun-2025 09:30 RNS
Total Voting Rights 30-Jun-2025 09:30 RNS

HCM Newspaper Links

Chinese medicine firm employs Cambridge Universi... 23-Dec-2009 Guardian
Joint venture offers food for growth 09-Oct-2009 The Scotsman
Chi-Med unveils maiden profit 31-Jul-2009 The Scotsman
Chi-Med happy with drug tests 14-Jul-2009 The Scotsman
'Watershed' year depends on US drugs trial says ... 17-Mar-2009 The Scotsman

HCM Tips & Analysis

Questor: Hutchison China Meditech 03-Jul-2007 Telegraph
The Week Ahead: Wolseley investors seek calm ami... 19-Mar-2007 The Independent
The Investment Column: Hutchison China MediTech 21-Nov-2006 The Independent
Shares That Sound Good 02-Jun-2006 Motley Fool UK

HCM News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HCM Market Data

Currency UK Pounds
Share Price 225.00p
Change Today 0.50p
% Change 0.22 %
52 Week High 325.00p
52 Week Low 189.00p
Volume 41,560
Shares Issued 872.11m
Market Cap £1,962.25m
Beta 0.06
RiskGrade 226

HCM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
42.36% below the market average42.36% below the market average42.36% below the market average42.36% below the market average42.36% below the market average
34.88% below the sector average34.88% below the sector average34.88% below the sector average34.88% below the sector average34.88% below the sector average
Price Trend
20.72% below the market average20.72% below the market average20.72% below the market average20.72% below the market average20.72% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Income Not Available
Growth
43.58% below the market average43.58% below the market average43.58% below the market average43.58% below the market average43.58% below the market average
86.67% below the sector average86.67% below the sector average86.67% below the sector average86.67% below the sector average86.67% below the sector average

HCM Dividends

No dividends found

Trades for 11-Aug-2025

Time Volume / Share Price
16:14 139 @ 225.00p
16:12 620 @ 225.00p
16:12 1,500 @ 225.00p
16:12 1,500 @ 225.00p
16:11 700 @ 227.98p

HCM Key Personnel

Chair Dan Eldar
CEO Weiguo Su

Top of Page